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The interaction between silence information regulator 1 protein
(Sir1p) and origin recognition complex 1 protein (Orc1p), the
largest subunit of the origin recognition complex, plays an impor-
tant role in the establishment of transcriptional silencing at the
cryptic mating-type gene loci in Saccharomyces cerevisiae. Sir1p
binds the N-terminal region of Orc1p encompassing a Bromo-
adjacent homology (BAH) domain found in various chromatin-
associated proteins. To understand the molecular mechanism of Sir
protein recruitment, we have determined a 2.5-Å cocrystal struc-
ture of the N-terminal domain of Orc1p in complex with the
Orc1p-interacting domain of Sir1p. The structure reveals that Sir1p
Orc1p-interacting domain has a bilobal structure: an  N-termi-
nal lobe and a C-terminal lobe resembling the Tudor domain royal
family fold. The N-terminal lobe of Sir1p binds in a shallow groove
between a helical subdomain and the BAH domain of Orc1p. The
structure provides a mechanistic understanding of Orc1p–Sir1p
interaction specificity, as well as insights into protein–protein
interactions involving BAH domains in general.
structure  transcriptional silencing
Epigenetic control of gene expression involves the assembly ofhigher order chromatin structures. In the budding yeast
Saccharomyces cerevisiae, cryptic mating-type genes, HML and
HMR, are epigenetically silenced. Genetic and biochemical
studies have identified cis- and trans-acting factors required for
the establishment and maintenance of transcriptional silencing
at the HM loci (1). The silent HM loci are flanked by specific
cis-acting DNA sequences called the E and I silencers, which
contain two or more binding sites for DNA-binding proteins, the
origin recognition complex (Orc), Rap1p, and Abf1p (2–6).
Silencing at the HM loci also requires four silent information
regulator (Sir) proteins, Sir1p, Sir2p, Sir3p and Sir4p (7, 8).
Orc is a six-protein complex important for initiation of DNA
replication and transcriptional silencing (2, 9, 10). The N-
terminal domain (NTD) of Orc1p, the largest subunit of Orc, is
specifically required for transcriptional silencing at the HM loci
(11). The NTD of Orc1p is220 residues in length, and it shares
50% amino acid identity with the N-terminal region of Sir3p.
The NTD of Orc1p interacts with Sir1p, and this interaction is
important for recruiting other SIR proteins to the HM loci as
Sir1p also interacts with Sir4p (12). In HM and telomeric
silencing, Sir4p forms a complex with Sir2p, and the Sir2pSir4p
complex is joined by Sir3p (13–15). Sir2p is a NAD-dependent
histone deacetylase (16–18), whereas Sir3p and Sir4p appear to
have structural roles. Sir3p and Sir4p can self-associate, interact
with Rap1p, and bind to the N-terminal tails of histone H3 and
H4 (19, 20). This complex network of protein–protein interac-
tions is responsible for the assembly of repressive higher-order
chromatin structures at the HM loci.
The NTD of Orc1p contains a bromo-adjacent homology
(BAH) domain (21), which is also present in a number of other
chromatin-associated proteins, such as Sir3p, the predominant
mammalian DNA methyltransferase DNMT1, the yeast RSC
nucleosome remodeling complex subunits RSC1 and RSC2, and
the MTA1 subunit of histone deacetylase complexes. We have
previously determined the Orc1p NTD structure and discovered
that the major Sir1p-interaction region is located in a helical
subdomain (H-domain) tethered to the predominant -sheet
BAH domain (22). The Orc1p-interacting domain (OID) is
located in the C-terminal region of Sir1p, and it contains no
recognizable sequence motifs (12, 23, 24). Interestingly, Orc1
NTD in higher eukaryotes interacts with HP1, and this interac-
tion is thought to be important for heterochromatin formation
(25, 26). Thus, Orc1 NTD appears to have an evolutionarily
conserved function of recruiting silencing proteins to chromatin,
although the structural bases for these specific protein–protein
interactions are poorly understood.
To understand the structural basis for Orc1p–Sir1p binding
specificity and to provide insight into the mode of protein–
protein interaction involving BAH domain proteins, we have
determined a 2.5-Å structure of the Orc1p NTD in complex with
Sir1p OID. The structure reveals that Sir1p OID has an 
structure rich in -strands. Sir1p OID binds in a cleft formed
between the BAH domain and H-domain. The detailed struc-
tural information provides important insights into the mecha-
nisms of heterochromatin formation in yeast.
Materials and Methods
Protein Methods. The Orc1p NTD–Sir1p OID complex was
produced by coexpression in BL21(DE3) Escherichia coli cells
using two T7 expression plasmids carrying the respective cDNA
fragments. Sir1p OID (amino acids 480–612) was expressed as
a C-terminal poly(histidine)-tagged protein by using a pET23a
vector (Novagen). Orc1p NTD (amino acids 1–219) was ex-
pressed by using a pMR101 vector (American Type Culture
Collection). Recombinant Orc1p NTD has a natural, untagged
N terminus. The complex was purified by column chromatog-
raphy on Hi-Trap Ni, Hi-Trap S, and Superdex-75 columns
(AP-Biotech). The purified complex was concentrated to 46
mgml in a buffer containing 10 mM Tris (pH 6.8), 0.2 M NaCl,
and 1 mM dithiotreitol for crystallization studies. Selenomethi-
onine (SeMet)-substituted protein complex was expressed in a
methionine-requiring auxotroph, DL41(DE3), by using a de-
fined medium supplemented with SeMet (27). The SeMet Orc1p
NTD–Sir1p OID complex was purified and crystallized in a
manner similar to that used for the native protein complex.
Crystallographic Methods.The protein complex was crystallized by
hanging-drop vapor diffusion in a condition containing 0.1 M
Mes, pH 6.2, and 4.0 M NaCl. The crystal has an I222 symmetry
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with cell dimensions of a 70.00 Å, b 137.21 Å, and c 139.77
Å. All diffraction data were collected at 100 K at the X26C
beamline of the National Synchrotron Light Source
(Brookhaven National Laboratory, Upton, NY). Data were
processed by using the HKL program (28), and the statistics are
shown in Table 1. The crystals appear to be sensitive to radiation
damage during a prolonged period of data collection.
The structure was solved by combining the phases obtained
from three sources: (i) molecular replacement by using the
Orc1p NTD structure (Protein Data Bank ID code 1M4Z) as a
search model; (ii) two-wavelength anomalous diffraction from a
selenomethionine crystal; and (iii) single-wavelength isomor-
phous and anomalous scattering data from a Pt derivative
(obtained by soaking a native crystal in the presence of 2 mM
K2PtCl4 for 6 h). The three sets of phases were combined and
extended to 2.5-Å resolution with iterative cycles of solvent
flattening and phase recombination by using the PHASES pro-
gram suite (29). Model building was carried out by using the
graphic program O (30), and structure refinement was carried
out by using CNS (31). Phasing and refinement statistics are
shown in Table 1. Figures were prepared with the programs
MOLSCRIPT (32), RASTER3D (33), and PYMOL (34).
Results and Discussion
Phase combination and extension produced a high-quality elec-
tron density map (Fig. 1A), which allowed unambiguous assign-
ment of Orc1p NTD (amino acids 1–219) and Sir1p OID (amino
acids 480–612) residues (Fig. 1B). Sir1p and Orc1p each contain
a disordered internal segment: residues 578–588 in Sir1p and
residues 22–36 in Orc1p. The refined structure has good stere-
Table 1. Summary of crystallographic analysis
Data sets Native K2PtCl4 Se inflection Se peak
Resolution, Å 2.4 2.8 3.0 3.0
Measured reflections 221,761 244,037 164,458 184,393
Unique reflections 26,351 18,210 13,988 13,783
Average I 21.1 24.0 15.8 13.8
Completeness, % (I  0) 94.3 (85.5) 97.0 (98.6) 96.4 (89.6) 97.3 (92.4)
Rmerge, %* 5.4 (39.6) 8.2 (17.5) 6.8 (35.7) 8.0 (30.4)
Phasing power (isoano)† —— 1.621.49 —0.81 1.072.03
Figure of merit — 0.39 0.45
Refinement
Resolution range, Å 50.0–2.5
RfactorRfree, %‡ 22.026.0
Protein atoms, n 2,612
Water molecules, n 164
rms deviations
Bond lengths, Å 0.007
Bond angles, ° 1.41
—; not applicable.
*RmergeIII,where Iand Iare theaveraged intensity ofmultiplemeasurements of the same reflection.
The summation is over all the observed reflections.
†Phasing power rms (FHE), where FH is the calculated structure factor of the heavy atoms and E is the residual
lack of closure. Isomorphous (iso) and anomalous (ano) contributions are separately shown.
‡RfactorFo FcFo, where Fo denotes the observed structure factor amplitude and Fc denotes the structure
factor calculated from the model.
Fig. 1. Structure determination. (A) A section of phased-extended electron density map surrounding the Orc1p NTD–Sir1p OID interface. The 2.5-Å electron
density map is contoured at 1.0  level. (B) A ribbon diagram showing the overall structure of the Orc1p NTD–Sir1p OID complex. Orc1p is shown in cyan, and
Sir1p is shown in yellow. Red dashed lines indicate disordered loops.
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ochemical quality: 86% of the main chain  angles are in the
most favored region, and none in the disallowed region of the
Ramachandran plot, calculated by using PROCHECK (35).
Structure of Sir1p OID. Sir1p OID does not have any recognizable
sequence motifs that can aid the understanding of Orc1p–Sir1p
interaction (Fig. 2A). The crystal structure reveals that Sir1p
OID is folded into an elongated structure rich in -strands (Fig.
2B). The structure consists of two topologically separable lobes
packed against each other (Fig. 2C). The N-terminal lobe is
formed by four antiparallel -strands (1–4) and two helices
(A and B). The two helices are packed against the same side
of the -sheet (Fig. 2B). The C-terminal lobe consists of five
antiparallel -strands (5–9) that are arranged in a tubular
structure. Additionally, two short helices (C and D) flank the
first strand, 5, in the C-terminal lobe (Fig. 2B). Helix D
appears to be important for stabilizing the packing of the two
Sir1p OID lobes, because it interacts extensively with amino
acids located at one side (opposite to the side occupied by A
and B) of the N-terminal -sheet (Fig. 2B).
The overall fold of Sir1p OID does not resemble any known
structures, because structural similarity searches using the DALI
server did not yield significant matches. It is clear from the
cocrystal structure that the N-terminal lobe is involved in the
interaction with Orc1p (Fig. 1B). The distinct tubular arrange-
ment of the -strands in the C-terminal lobe is reminiscent of a
Tudor-like structure. Fig. 2D shows the Tudor domain structure
of survival motor neuron (SMN), the spinal muscular atrophy
protein (36). The Sir1p C-terminal lobe superimposes well with
the SMNTudor domain. The two structures have a rms deviation
of 1.06 Å, using 20 residues on 6, 8, and 9 of Sir1p OID for
alignment with corresponding residues on 1, 2, and 3 of the
SMN Tudor domain, respectively. Tudor and related domains
form a so-called ‘‘royal family’’ of domains that function in
protein–protein interactions, sometimes by means of methylated
arginine or lysine residues (37). It is interesting that Sir1p, like
many other chromatin-associated proteins, contains a domain of
the Tudor domain royal family, which suggests that the Sir1p
Tudor-like domain may also have a function in protein–protein
interactions.
Structure of Orc1p NTD.Orc1p NTD contains a core BAH domain
that consists mainly of -strands and a helical H-domain that is
important for Sir1p-binding (22). Two antiparallel -helices
located at the C terminus of Orc1p NTD pack against the BAH
domain and appear to be important for stabilizing the mainly
-sheet BAH fold (Fig. 3). Comparing the Sir1p-bound Orc1p
structure with that of the free Orc1p NTD reveals two main
differences: (i) Nine residues at the N terminus of Orc1p have
a very different conformation, and (ii) helix D and the pre-
ceding loop in the H-domain move toward the bound Sir1p in the
present structure. The N-terminal end of D shifted by 4 Å.
The difference in the N terminus appears to be due to
self-interaction between Orc1p NTD molecules in the crystal
lattice. In the structure of Orc1p NTD alone, the N-terminal tail
of approximately 8 to 10 residues is involved in the interaction
between two Orc1p NTDmolecules within the same asymmetric
unit (22). This region is also involved in protein–protein inter-
actions between two symmetry-related Orc1p NTDmolecules in
the present structure, but the way they interact has changed. In
the present structure, the N terminus of Orc1p starts at Ala-2;
the initiating formyl-methionine is likely removed by cotransla-
tional processing during expression. Orc1p NTD crystallized
alone was with a construct having four artificial amino acids at
the N terminus (22). This amino acid difference may contribute
to the altered conformation of the N terminus of Orc1p in the
two structures.
The movement of D and adjacent loops in the H-domain
appears to be induced by the binding of Sir1p OID (Figs. 1B and
4). Sir1p contacts three Orc1p regions: region I encompassing
Fig. 2. Sir1p OID structure. (A) Sequence and secondary structure of Sir1p OID. Red dashed lines indicate disordered regions in the crystal structure. A plus sign
is shown above the sequence to indicate every 10 residues. Three Orc1p-interacting regions, indicated by encircled numbers, are shown as white letters over a
blue background. (B) Sir1p OID structure shown in a ribbon representation. Secondary structure elements are labeled. (C) A schematic drawing of the folding
topology of Sir1p OID. The shaded region is involved in Orc1p binding, and the dashed red line indicates a disordered loop. (D) The C-terminal lobe of Sir1p OID
has a Tudor-like structure. (Left) The SMN Tudor domain is shown in a ribbon representation. (Right) A superposition of the C-terminal lobe of Sir1pOID (yellow)
with the SMN Tudor domain.
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residues 61–66, which is located in the BAH domain; region II
spanning residues 92–98, which is on the loop connecting 6 of
the BAH domain with B in the H-domain; and region III
consisting of D and the following loop (Fig. 3B). Amino acids
in the three regions form a Sir1p-binding cleft (Figs. 3A and 4).
Orc1p–Sir1p Interaction. Sir1p interacts with Orc1p mainly
through residues located in three regions of the Sir1p OID: (i)
1-turn-2, (ii) 3-turn-4, and (iii) three residues on A (Fig.
2A). These residues are all located in the N-terminal lobe of
Sir1p OID, and they contact Orc1p residues in the cleft formed
between the BAH and H-domains (Fig. 4A). This interaction
buries 1,046 Å2 of protein surface area, which is within the range
of surface areas common to specific and stable protein–protein
interactions observed in many crystal structures. In the first
Orc1p-interacting region (Fig. 2A), Pro-492Sir1, Arg-493Sir1, and
Tyr-489Sir1 (Orc1p and Sir1p amino acids will be distinguished by
a superscript hereafter) interact with Orc1p by means of hydro-
phobic and hydrogen bond interactions, whereas the rest of the
amino acids in this region contact Orc1p through van der Waals
interactions. Pro-492Sir1and Arg-493Sir1 are located at the apex of
the 1–2 turn, and they make important contacts with Orc1p.
Fig. 4B shows that Pro-492Sir1 binds in a shallow hydrophobic
pocket formed by Trp-93Orc1, Phe-94Orc1, Val-96Orc1, and Pro-
98Orc1 located in the N-terminal loop connecting the BAH
domain with the H-domain (region II), and Asn-120Orc1 and
Phe-123Orc1 of helix D in the H-domain (region III). The
aliphatic portion of the Arg-493Sir1 side chain packs against
Phe-94Orc1, and the guanidinyl group of Arg-493Sir1 makes
hydrogen bonds with the carbonyl groups of Ala-63Orc1 and
Fig. 3. Orc1p NTD structure. (A) Superposition of Orc1p NTD structures of that in the presence (cyan) or absence (beige) of Sir1p OID. In the orientation shown,
the BAH domain is on top and the H-domain is at the bottom. The Sir1p NTD-binding cleft is indicated with a purple arc. Three regions involved in Sir1p binding
are indicatedwith green (region I), yellow (region II), or red (region III) traces. (B) Alignment of Orc1p and Sir3p NTD sequences. Orc1p NTD secondary structures,
with those in the H-domain shown in red, are indicated above the sequences. Dashed red lines indicate disordered regions. Three Sir1p-interacting Orc1p
segments are enclosed in red boxes, and the three regions are labeled with roman numerals.
Fig. 4. Orc1p–Sir1p interaction. (A) A surface representation of the Orc1p NTD–Sir1p OID complex. Orc1p NTD and Sir1p OID are shown in semitransparent
surfaces (cyan and yellow, respectively) superimposed with their respective ribbon models. (B) A detailed view of the protein interface. Orc1p NTD is shown in
a surface representation superimposed with the ribbonmodel (cyan) and a stick model of residues interacting with Sir1p (cyan, carbon; blue, nitrogen; and red,
oxygen). Sir1p OID is shown as a ribbon model (yellow) superimposed with a stick model of residues interacting with Orc1p (green, carbon; blue, nitrogen; and
red, oxygen). Orc1p and Sir1p residues are indicated with cyan and magenta labels, respectively.
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Gly-64Orc1 (Figs. 4B and 5). Tyr-489Sir1 is located in 1, and its
ring is packed against the aliphatic portion of Lys-121Orc1 (Fig.
5). Furthermore, the hydroxyl group of Tyr-489Sir1 interacts with
Ser-124Orc1 and Lys-129Orc1 through a water molecule.
Leu-504Sir1, Ala-505Sir1, and Glu-506Sir1 in the second Orc1p-
interaction region directly interact with Orc1p (Fig. 5). Leu-
504Sir1 and Ala-505Sir1 interact with Orc1p hydrophobically
through the packing of Leu-504Sir1 with Trp-93Orc1 and Ala-
505Sir1 with Phe-94Orc1 and Thr-65Orc1. Additionally, the car-
bonyl group of Ala-505Sir1 forms a hydrogen bond with Arg-
92Orc1. Glu-506Sir1 makes a hydrogen bond with the hydroxyl
group of Thr-65Orc1. The third Orc1p-interacting region is
located in A: Arg-516Sir1 makes two hydrogen bonds with the
side chain oxygen atom and the main chain carbonyl of Glu-
61Orc1, whereas Thr-519Sir1 interacts with the carbonyl of Ala-
62Orc1 through a water molecule, and Leu-520Sir1 and Ala-63Orc1
are in van der Waals contacts.
Specificity of Orc1p–Sir1p Interaction. Our previous structural,
biochemical, and genetic studies indicated that the H-domain of
Orc1p NTD is important for interaction with Sir1p (22). The
Orc1p interaction region in Sir1p has also been mapped by
genetic and biochemical methods (24). The cocrystal structure
presented here directly confirms the results of these earlier
studies and provides insights into the mode of Orc1p–Sir1p
interaction. First, this study identifies a region in the BAH
domain that encompasses Orc1p residues 61–66 (Fig. 3B, region
I), to be important for the interaction between Orc1p and Sir1p.
Second, the structure enables the precise identification of Sir1p-
interaction regions within the H-domain (Fig. 3B, regions II and
III), which is important for understanding the specificity of
Orc1p–Sir1p interactions.
A great deal about the Orc1p–Sir1p interaction specificity is
learned from comparing the structure with the knowledge
gained from biochemical and genetic studies of Orc1p and
Sir3p. An interesting observation is the that Orc1p NTD is
highly homologous to Sir3p NTD, and the two domains are
functionally interchangeable in HM silencing when tethered to
the rest of Orc1p or Sir3p (11, 38). However, Sir3p NTD is not
known to interact with Sir1p (38). Previously, we constructed
a Sir3p–Orc1p swap (SOS) mutant replacing the putative Sir3p
H-domain (amino acids 96–130) with that of the Orc1p
H-domain (Fig. 3B). The SOS mutant of Sir3p gains the ability
to interact with Sir1p (22), which suggests that Orc1p region
I is unlikely to be a major determinant of Sir1p binding because
this region is the same in the wild type and SOS mutant of
Sir3p. The present cocrystal structure also rules out region II
as a major determinant of Sir1p binding specificity because the
only two residues different between Orc1p and Sir3p in this
region are not involved in Sir1p binding. Examination of the
structure suggests that residues Asn-117Orc1, Asn-120Orc1, Lys-
121Orc1, and Ser-124Orc1 in helix D are likely to be major
determinants of Sir1p binding specificity, because they directly
interact with Sir1p in the structure and Sir3p has different
amino acids at the corresponding positions, which may account
for Sir3p’s inability to interact with Sir1p OID. Asn-117Orc1 is
unlikely to play a significant role because it interacts with Sir1p
only weakly through van der Waals contacts, which is consis-
tent with our previous observation that an alanine substitution
of Asn-117Orc1, together with alanine substitutions of several
other H-domain residues, has no HMR silencing defects (on-
line supplementary material of ref 22). Thus, this analysis
concludes that Asn-120Orc1, Lys-121Orc1, and Ser-124Orc1 are
important for Sir1p binding. A testable prediction would be
that a Sir3p mutant replacing Lys-120Sir3, Asp-121Sir3, and
Phe-124Sir3 with the corresponding Orc1p residues should gain
the ability to interact with Sir1p OID.
Previous genetic analysis of Sir1p mutations that are defective
in silencer recognition demonstrated the requirement of key
amino acids (Tyr-489Sir1, Val-490Sir1, Ser-491Sir1, Arg-493Sir1,
and Ala-505Sir1) for interaction with Orc1p (23). These residues
are located in the Orc1p-interacting regions identified from the
structural study presented here (Fig. 2A). A more recent study
identified seven additional amino acids (Phe-494Sir1, Leu-501Sir1,
Asp-503Sir1, Leu-504Sir1, Trp-537Sir1, Cys-595Sir1, and Leu-
608Sir1) as being required for the interaction (24). All of these
residues, except Asp-503Sir1and Leu-504Sir1, play a structural role
of the Sir1p OID domain. Leu-504Sir1 interacts with Trp-93Orc1
Fig. 5. A stereo viewofOrc1p–Sir1p interaction. The protein interface is viewed froman angle approximately perpendicular to that in Fig. 4B (i.e., as from right
to left in Fig. 4B). Orc1p is shown as a ribbon model superimposed with a stick model of relevant residues. Sir1p residues involved in interaction with Orc1p are
shown in a stick model. A same coloring scheme as in Fig. 4B is used here.
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(Fig. 5) and Asp-503Sir1 interacts with Orc1p by means of van der
Waals contact with Gly-64Orc1. Another important role of Asp-
503Sir1 is to stabilize the side chain conformation of Arg-493Sir1,
which is involved in multiple contacts with Orc1p.
Our structural study also reveals a previously unknown third
Orc1p-interacting region in helix A. Sir1p has an interesting
Orc1p-interacting mode: Two small residues, Pro-492Sir1 and
Ala-505Sir1, are situated at the tips of -turn- motifs and they
spearhead the interaction with Orc1p by binding in two shallow
hydrophobic pockets. The small size of the two residues is
crucial because it allows ideal surface complementarity be-
tween the two interacting proteins. The C-terminal lobe of
Sir1p does not interact with Orc1p (Fig. 4). We noted that the
C-terminal lobe has a structure similar to the Tudor domain
superfamily members, many of which have been implicated in
protein–protein interactions (37). It is possible that the struc-
tural similarity also indicates a protein–protein interaction
function of the Sir1p OID C-terminal lobe. It has been shown
that Sir4p interacts with Sir1p through a region encompassing
OID (24); thus, it is an attractive hypothesis that the Tudor-like
structure of the C-terminal lobe is involved in interaction with
Sir4p. Sir1p has also been shown to be part of the yeast
centromeric chromatin, and it interacts with the largest subunit
of chromatin assembly factor I (39). It would be interesting to
know whether the recruitment of Sir1p to centromeres is also
mediated through the OID.
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